Allergy Tablets Recalled Nationwide Over Ranitidine Contamination

What Was Recalled?

Unique Pharmaceutical Laboratories, a division of J. B. Chemicals & Pharmaceuticals Ltd., announced a voluntary nationwide recall of four lots of Cetirizine Hydrochloride Tablets USP 5 mg on July 18, 2026. The U.S. Food and Drug Administration posted the company announcement on July 20, 2026. Cetirizine is the generic form of the antihistamine sold under the brand name Zyrtec; the 5 mg tablet is a low-dose form often taken by children and older adults.

According to the announcement, the recall covers 100-count HDPE bottles distributed by Rising Pharma Holdings Inc. under NDC 16571-401-10, lot numbers GY825029, GY825030, GY825031, and GY825032, all with an expiration date of 10/2028. The product was distributed nationwide to wholesalers and retailers, which includes Texas pharmacies.

The reason for the recall is potential cross contamination with ranitidine, a drug formerly sold as Zantac and used for heartburn, ulcers, and indigestion. The company says the problem came to light through a product complaint after a pharmacy technician noticed red dots and discoloration on tablets while counting and bottling them. National outlets including CBS News and ABC News reported the recall this week.

What Risk Does the Notice Describe?

The company’s risk statement says that for consumers with a hypersensitivity to the ingredients in ranitidine, there is a reasonable probability that swallowing a cetirizine tablet contaminated with ranitidine could cause serious adverse events, including severe hypersensitivity reactions and anaphylaxis. The announcement lists low blood pressure, difficulty breathing, difficulty swallowing, swelling of the throat and face, generalized itching, hives, and loss of consciousness, and describes those reactions as life-threatening.

The company also states that as of the announcement it had not received any reports of adverse events related to this recall. In other words, this is a warning about a risk that was caught in a pharmacy, not a report of known injuries. The FDA notes that when a company announces a recall, the agency posts the announcement as a public service and does not endorse the product or the company.

The FDA announcement tells consumers to contact their physician or health care provider if they have experienced any problem that may be related to the product, gives the distributor’s consumer contact information, and explains how to report a problem through the agency’s MedWatch program.

Who Can Be Affected?

• Anyone in Texas who bought or was dispensed 5 mg cetirizine tablets from one of the four recalled lots
• Parents and caregivers who give a low-dose antihistamine to a child
• People with a known sensitivity or allergy to ranitidine or related medications
• Anyone who had an unexplained severe allergic reaction after taking a generic allergy tablet

What Kind of Claim Might Apply?

Attorneys who handle Texas defective product cases generally describe several paths that can apply when a medication reaches a consumer contaminated with something it should not contain:

• A products liability claim — Chapter 82 of the Texas Civil Practice & Remedies Code governs products liability actions in Texas, including claims based on a manufacturing defect, and sets out the roles of manufacturers and sellers in the chain of distribution.
• A claim for a person who was seriously hurt — someone who suffered an anaphylactic reaction may face emergency care, hospitalization, and follow-up treatment, and Texas law lets an injured person seek compensation for medical bills, lost income, and other harms.
• A wrongful death and survival claim — if a reaction to a defective product causes a death, Chapter 71 generally allows a surviving spouse, children, and parents to seek compensation, with a survival claim belonging to the estate.
• Preserving the proof — attorneys handling recall cases often ask people to keep the bottle, the label with its lot number, any remaining tablets, the pharmacy receipt or printout, and the medical records from the reaction. Those items are what connect a specific injury to a specific recalled lot, and they are easy to throw away.

None of this assumes that anyone has been harmed by these lots — the company says no adverse events have been reported. It describes the questions Texas attorneys say people ask after a drug recall, and the evidence they typically want preserved.

Why Acting Quickly Can Matter

For most Texas personal injury and wrongful death cases, the statute of limitations is generally two years, and Chapter 16 also contains a separate repose period for products liability claims — a lawyer can explain how the deadlines apply to a specific situation. Physical proof is the bigger practical problem: recalled bottles get returned to the pharmacy or thrown out, and the lot number goes with them. Many people choose to have a lawyer look at the paperwork early, while the bottle and the pharmacy records still exist.

Sources

1. FDA — Unique Pharmaceutical Laboratories issues voluntary nationwide recall of Cetirizine Hydrochloride Tablets USP 5 mg due to potential cross contamination with ranitidine
2. CBS News — Antihistamine recall across the U.S. triggered by heartburn drug contamination risk, FDA says
3. ABC News — Allergy medication recalled for potential cross-contamination that could be life-threatening, FDA says
4. FDA MedWatch — Safety information and adverse event reporting program
5. Texas Civil Practice & Remedies Code, Chapter 82 (Products Liability)
6. Texas Civil Practice & Remedies Code, Chapter 71 (Wrongful Death; Survival)
7. Texas Civil Practice & Remedies Code, Chapter 16 (Limitations)